Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The objective of this paper is to investigate the association between patterns of anti-dsDNA antibody isotypes and specific clinical manifestations (categorized in renal, musculoskeletal, cutaneous, hematological, pulmonary, neurologicaland cardiac). Sera of 202 systemiclupus erythematosus(SLE) patients, 33 patients suffering from other autoimmune diseases and 115 healthy blood donors were analysed for anti-dsDNA antibodies by IgG-, IgA- and IgM-specific ELISA, Farr-assay and CLIF. A subset of 24 SLE patients was investigated in a longitudinal study over a period of one to six years. Disease activity of 105 SLE patients was measured according to the ECLAM score. In the cohort of SLE patients 63% were positivefor the IgG class, 40% for the IgA and 57% for the IgM class specific anti-dsDNA ELISA. Sensitivity (79%) and specificity (99%) for the diagnosis of SLE appeared to be highest for the ELISA measuring all isotypes of anti-dsDNA antibodies. The concentrations of anti- dsDNA isotypesshowed a strong correlationwith disease activity. Analysing the relationship between IgG, IgA and IgM anti-dsDNA antibody isotypes and clinical manifestation, we found a significant associationof the IgM isotypewith cutaneousinvolvementand of the IgG isotypewith lupus nephritis. The IgG/IgM ratio of anti-dsDNA antibodies represented a significant parameter to distinguish patients with lupus nephritis from those without renal involvement. In the longitudinal study, a continuous ratio under 0.8 was associated with absence of renal involvement throughout the investigatedperiod. In conclusion, the evaluationof anti-dsDNA isotypesprovidesa diagnostictool to define subsets within SLE patients with different clinical manifestations. In particular, the IgG/IgM ratio of anti-dsDNA antibodies could be used as a prognostic marker for lupus nephritis during the course of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dissociation studies of DNA/anti-DNA complexes in relation to anti-DNA avidity
Smeenk, R. J. T., Van Rooijen, A., & Swaak, T. J. G. (1988) · Journal of Immunological Methods · doi:10.1016/0022-1759(88)90438-3 · Cited by 40
Wigand (1997) · doi:10.1007/s003930050020 · Cited by 10
Cited by
Mosca, M., Tani, C., Aringer, M., Bombardieri, S., Boumpas, D., Brey, R., Cervera, R., Doria, A., Jayne, D., Khamashta, M. A., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117200 · Cited by 377
Protective Roles of Natural IgM Antibodies
Grönwall, C., Vas, J., & Silverman, G. J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00066 · Cited by 357
Fifty years of anti-ds DNA antibodies: are we approaching journey's end?
Isenberg, D. A., Manson, J. J., Ehrenstein, M. R., & Rahman, A. (2007) · Rheumatology · doi:10.1093/rheumatology/kem112 · Cited by 281
Enocsson, H., Sjöwall, C., Wirestam, L., Dahle, C., Kastbom, A., Rönnelid, J., Wetterö, J., & Skogh, T. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.140677 · Cited by 73
Jaekel, H.-P., Trabandt, A., Grobe, N., & Werle, E. (2006) · Lupus · doi:10.1191/0961203306lu2308oa · Cited by 43
Metadata
- Authors
- Förger, F., Matthias, T., Oppermann, M., Becker, H., & Helmke, K.
- Venue
- Lupus
- Publisher
- SAGE Publications
- Published
- 2004-01
- Volume
- 13
- Issue
- 1
- Pages
- 36-44
- ISSN
- 0961-2033 (ISSN-L)
- 1477-0962
- OpenAlex
- W2045539112
- Cited by
- 139
- References
- 2
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. https://app.cochat.ai/papers/10.1191/0961203304lu485oa
- The paper
- Förger, F., Matthias, T., Oppermann, M., Becker, H., & Helmke, K. (2004). Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus. https://doi.org/10.1191/0961203304lu485oa
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.